OF SPECIAL INTEREST
Novartis hypertension drug approved
Scientists examine pain relief and addiction
Appointment
Prevention of respiratory depression becomes safety foundation's new goal
FDA's sentinel network
FDA investigating nonprescription cough and cold products
Corrections
Effect of tobacco on INR
Effect of tobacco on INR
Clinical pharmacy services in a home-based palliative care program
Specializing in pediatric hematology and oncology
The role of second-generation antipsychotics in the treatment of psychotic disorders
Ensuring the competence of pharmacy technicians
Polymyxin antibiotics for gram-negative infections
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities
Azithromycin for the secondary prevention of coronary artery disease
Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations
Pharmacists versus nonpharmacists in adverse drug event detection
Multidisciplinary approach to inpatient medication reconciliation in an academic setting
Does your pharmacy have a compounding isolator?
No ordinary time
ASHP Therapeutic Position Statement on the Use of Second-Generation Antipsychotic Medications in the Treatment of Adults with Psychotic Disorders
Summary of the Proceedings of the 2006 ASHP National Residency Preceptors Conference
Actions of the ASHP Board of Directors—meeting of January 11–12, 2007
ASHP professional policy recommendations — invitation to comment